Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review

Crawshaw, Alison F; Yasmin, Farah; Deal, Anna; Rustage, Kieran; Hayward, S E; Carter, Jessica; Knights, Felicity; Goldsmith, Lucy; Campos-Matos, Inês; Wurie, Fatima; Majeed, Azeem; Bedford, Helen; Forster, Alice S.; Hargreaves, Sally

doi:10.1016/s1473-3099(22)00066-4

Cited by 127 publications

(141 citation statements)

References 109 publications

Supporting

Mentioning

110

Contrasting

Order By: Relevance

“…Concerns regarding the safety of new vaccines and the structures in place to monitor these new vaccines have been found to be signi cant factors affecting COVID-19 booster vaccine acceptance elsewhere. 10,[21][22][23] Willingness to receive a COVID-19 booster vaccine among the study population was high. These ndings are similar to studies assessing willingness for booster vaccines in Europe and North America.…”

Section: Discussionmentioning

confidence: 94%

“…[7][8][9] Migrants generally face additional accessibility barriers to health care that have been exacerbated by the COVID-19 pandemic, such as unmet language requirements, limited access to culturally appropriate services, and limited entitlement to subsidised health care. 7,[10][11][12][13] In addition, migrant communities have had limited input and engagement in the development of public health messages to promote COVID-19 vaccinations, contributing to lower vaccination coverage against COVID-19. 10 As a result, migrants have higher hospitalisation and death rates than locally born populations.…”

Section: Introductionmentioning

confidence: 99%

“…7,[10][11][12][13] In addition, migrant communities have had limited input and engagement in the development of public health messages to promote COVID-19 vaccinations, contributing to lower vaccination coverage against COVID-19. 10 As a result, migrants have higher hospitalisation and death rates than locally born populations. 7,14,15 Recent analysis of COVID-19 death data in Australia revealed that migrants had an age-standardised death rate over 2.5 times higher than locally born populations, and migrants born in Middle Eastern countries have been subject to the highest age-standardised death rate at 29.3 deaths per 100,000 population per year in Australia.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study

Allen

Lambert

Yuen

et al. 2022

Preprint

View full text Add to dashboard Cite

Background Migrants have been disproportionally affected by COVID-19 in Australia. Vaccination against COVID-19 is a key pillar of Australia's public health response, but little is known about the willingness to receive booster vaccinations among migrants. This study aimed to assess the factors associated with a willingness to receive a COVID-19 booster vaccine among migrants living in Australia born in the World Health Organization’s Eastern Mediterranean Region (EMRO). Methods A cross-sectional survey was conducted from September to November 2021 (n = 300). Participants were questioned on booster vaccine willingness, sociodemographic characteristics, COVID-19 vaccine information needs and sources, and perceptions of COVID-19 vaccines. Univariate and multivariate logistic regression were used to assess factors associated with booster willingness. Results Most respondents (87%) had received two doses of COVID-19 vaccine, of which 81% were willing to receive a booster dose. About half of the participants reported high or very high needs for receiving information about “COVID-19 vaccines’ safety monitoring in Australia”, “COVID-19 vaccines protection against illness”, “Safety of COVID-19 vaccines used in Australia”, and “The Australian COVID-19 vaccination program”. People who were willing to receive a boost dose had significantly higher self-estimated knowledge of COVID-19 vaccines, confidence in COVID-19 vaccines and trust in the Australian government’s vaccine recommendations, and perceived COVID-19 as a greater risk compared to those who were unsure/hesitant. Both groups reported similar perceptions of their personal risks from COVID-19 but diverged on their views of COVID-19 as a broader health problem. There were no statistically significant differences between the two groups in terms of channels used to find information about COVID-19 vaccines. Factors associated with willingness to receive a COVID-19 booster vaccine in the multivariate logistic regression were age (OR:1.07, 95%CI:1.02–1.12), and no exposure to concerning news about COVID-19 vaccines (OR:3.71, 95%CI:1.51–9.08). Conclusion Vaccine acceptance and reported booster willingness was high. The results suggest the news and information seen may impact willingness to receive booster doses, even among those who have already received doses of COVID-19 vaccine. Addressing vaccine concerns and transparent communication about uncertainty should be a priority in the current and in future pandemics.

show abstract

Section: Discussionmentioning

confidence: 94%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study

Allen

Lambert

Yuen

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Consider strategies to overcome any barriers to health or vaccine systems (including vaccine hesitancy), eg, through outreach, longer appointment times, and translated patient information. 24 A toolkit to improve vaccine uptake is available from Doctors of the World (see box, ‘Additional educational resources’) and ECDC. 25 26 The UKHSA provides guidance on managing people who may have been vaccinated in other countries.…”

Section: What Clinical Issues To Consider?mentioning

confidence: 99%

“…Some populations might have a low uptake of vaccination for covid-19 (eg, survey data using non-probability convenience sampling found nearly a third of people surveyed in Afghanistan showed limited intent to vaccinate against covid-1923). Consider strategies to overcome any barriers to health or vaccine systems (including vaccine hesitancy), eg, through outreach, longer appointment times, and translated patient information 24. A toolkit to improve vaccine uptake is available from Doctors of the World (see box, ‘Additional educational resources’) and ECDC 2526.…”

Section: What Clinical Issues To Consider?mentioning

confidence: 99%

Initial health assessments for newly arrived migrants, refugees, and asylum seekers

Knights

Munir

Ahmed³

et al. 2022

BMJ

Self Cite

View full text Add to dashboard Cite

Sociodemographic Comparison of Children With High-risk Medical Conditions Referred vs Identified Through Screening Plus Outreach for COVID-19 Therapeutics

et al. 2022

View full text Add to dashboard Cite

ImportanceMinoritized groups are less likely to receive COVID-19 therapeutics, but few studies have identified potential methods to reduce disparities.ObjectiveTo determine whether screening plus outreach, when compared with referral alone, increases identification of vulnerable pediatric patients at high risk for severe disease eligible for COVID-19 therapeutics from low-resourced communities.Design, Setting, and ParticipantsA retrospective cohort study of COVID-19 medication allocation between January 1, 2022, and February 15, 2022, at Lurie Children’s Hospital, a quaternary care children’s hospital, in Chicago, Illinois. The cohorts were pediatric patients referred for COVID-19 therapeutics or with a positive SARS-CoV-2 polymerase chain reaction within the hospital system followed by outreach. Screening involved daily review of positive cases of SARS-CoV-2, followed by medical record review for high-risk conditions, and communication with clinicians and/or patients and families to offer therapy.ExposuresDiagnosis of COVID-19.Main Outcomes and MeasuresThe primary measure was difference in child opportunity index (COI) scores between the 2 cohorts. Secondary measures included presence and duration of symptoms at diagnosis, medication uptake, race and ethnicity, insurance type, qualifying medical condition, sex, primary language, and age.ResultsOf 145 total patients, the median (IQR) age was 15 (13-17) years, and most were male (87 participants [60.0%]), enrolled in public insurance (83 participants [57.2%]), and members of minoritized racial and ethnic groups (103 participants [71.0%]). The most common qualifying conditions were asthma and/or obesity (71 participants [49.0%]). From 9869 SARS-CoV-2 tests performed, 94 eligible patients were identified via screening for COVID-19 therapeutics. Fifty-one patients were identified via referral. Thirty-two patients received medication, of whom 8 (25%) were identified by screening plus outreach alone. Compared with referred patients, patients in the screening plus outreach group were more likely to have moderate, low, or very low COI composite scores (70 patients [74.5%] vs 27 patients [52.9%]); public insurance (65 patients [69.1%] vs 18 patients [35.3%]); and asthma or obesity (60 patients [63.8%] vs 11 patients [21.6%]). Patients in the referral group were more likely to be non-Hispanic White (23 patients [45.1%] vs 19 patients [20.2%]) and receive medication (24 patients [47.1%] vs 8 patients [8.5%]).Conclusions and RelevanceCompared with referral patients, screening plus outreach patients for COVID-19 medications were more socially vulnerable, with lower COI scores, and more likely to have asthma or obesity. Future studies should investigate communication strategies to improve uptake of these medications after outreach.

show abstract

Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review

Cited by 127 publications

References 109 publications

Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study

Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study

Initial health assessments for newly arrived migrants, refugees, and asylum seekers

Sociodemographic Comparison of Children With High-risk Medical Conditions Referred vs Identified Through Screening Plus Outreach for COVID-19 Therapeutics

Contact Info

Product

Resources

About